TOKYO, Feb. 18 /PRNewswire/ -- CLONTECH Laboratories Japan today announced the appointment of Mr. Junya Tominaga as President and the move to their new offices on March 1, 1999. Dr. Kenneth Fong, CEO of CLONTECH Laboratories, Inc. headquarters in Palo Alto, California , announced that Mr. Junya Tominaga will manage the sales and marketing, technical support services, distribution channels and scientific collaborations of CLONTECH Laboratories Japan Ltd. Dr. Fong indicates that: "Mr. Tominaga has excellent contacts in the Japanese scientific community, both among customers and other companies, having worked in this field for the past 20 years." A veteran of the life sciences industry, Mr. Tominaga spent the past six years as President of Molecular Dynamics Japan ; prior to that, he was President of Tomy Corporation, the MD distributor in Japan and a subsidiary of Tomy Seiko Inc. He received his Engineering Degree from Hosei University and has lived and studied in England and also worked in the US. In addition to the announcement of Mr. Tominaga, beginning March 1st, 1999 CLONTECH Japan will move its offices and distribution activities to: 2-1-9 Shinkawa, Chuo-Ku, Tokyo 1F: Shipping Center 6F: New Offices Tel: 03-3523-9777 Technical Support: 03-3523-9609 Order Desks: 03-3523-9780 Web Site: http://www.clontech.co.jp. FAX: -9771 Order FAX: -9781 Mr. Hiroyuki Masumoto, CLONTECH Laboratories' International Sales Manager states that: "The new offices and distribution center will enable the company to have enough inventory on-hand to improve the next day's delivery service while the well-trained technical support staff will be able to respond back immediately to end-user inquiries." Mr. Masumoto further indicates that "the Japanese-language catalog and other printed materials, seminars and web-site will enable local customers to communicate more effectively and directly with the staff in the Tokyo offices". About the Company Headquartered in Palo Alto, California, CLONTECH Laboratories (www.clontech.com) is a provider of innovative enabling technologies to the life sciences research market. Using their expertise in several areas including PCR, genetic reporter systems, RNA technology, gene expression systems, and differential gene expression, the Company produces a wide range of innovative biological systems, kits, and support products that have proven to be highly valuable tools in fields like drug discovery, cancer research, neurobiology, pharmacology, cell biology, genomics and functional genomics.
SOURCE CLONTECH Laboratories, Inc.